Intrinsiqs

Is Maravai LifeSciences Holdings, Inc. overvalued?

Maravai LifeSciences Holdings, Inc. (MRVI) — key valuation metrics and fundamentals.

No verdict
Price
$5.63
Fair value
Current P/E
Normal P/E
26.4
Market cap
$1.56B
Dividend yield
0.0%
Return on equity
-35.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MRVI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.